Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl Cysteine (NAC) inhalation spray for symptom control in COVID-19
IRCT20080901001165N55Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in coronavirus disease 2019 (COVID-19), sponsored by Baqiyatallah University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20080901001165N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001165N55.